cyanidin has been researched along with Fatty Liver, Nonalcoholic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Du, X; Fang, Z; Li, X; Liu, G; Loor, JJ; Peng, Z; Shen, T; Shi, Z; Shui, G; Song, Y; Wang, H; Wang, X; Wang, Z; Zhu, Y | 1 |
| Hwang, SL; Shih, PH; Yeh, CT; Yen, GC | 1 |
2 other study(ies) available for cyanidin and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Cyanidin-3-O-glucoside improves non-alcoholic fatty liver disease by promoting PINK1-mediated mitophagy in mice.
Topics: Animals; Anthocyanins; Glucosides; Humans; Mice; Mitophagy; Non-alcoholic Fatty Liver Disease; Protein Kinases | 2020 |
Synergistic effect of cyanidin and PPAR agonist against nonalcoholic steatohepatitis-mediated oxidative stress-induced cytotoxicity through MAPK and Nrf2 transduction pathways.
Topics: Animals; Anthocyanins; Cell Line, Tumor; Chromans; Drug Synergism; Extracellular Signal-Regulated MAP Kinases; Fatty Liver; Humans; Hydrogen Peroxide; JNK Mitogen-Activated Protein Kinases; Mitogen-Activated Protein Kinases; NF-E2-Related Factor 2; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Peroxisome Proliferator-Activated Receptors; Rats; Signal Transduction; Thiazolidinediones; Troglitazone | 2012 |